Éster etílico del ácido benzoico, mínimo 99 %, para síntesis, 250 ml, envase de vidrio

Methyl 6-bromopyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 10g

4-(5-((3-Benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid, 98%, 50mg

(1-Benzyl-1H-pyrazol-4-yl)boronic acid, 96.0%, 5g

4-Chloro-3-methylpyridine-2-carbonitrile, 98+%, 100mg

2-Amino-4-cyanothiazole, 95.0%, 5g

4-Iodo-5-methylisoxazole, 97.0%, 250mg

3-Benzoylpyrimidine-2,4(1H,3H)-dione, 98%, 2g

2-Methoxy-5-methyl-isonicotinonitrile, 98%, 100mg

6-Methylpyridine-2-thiol, 97.0%, 1g

6-(2-(Quinolin-2-yl)propan-2-yl)pyridin-2(1H)-one, 98%, 1g

(4-((4-Fluorobenzyl)carbamoyl)phenyl)boronic acid, 98%, 250mg

(1H-Imidazol-4-yl)methanamine dihydrochloride, 95.0%, 250mg